Estimating the incidence of breast cancer recurrence using administrative data

Warren J, Yabroff K (2015) Challenges and opportunities in measuring cancer recurrence in the United States: PubMed: NCBI. J Natl Cancer Inst 107:8

Vuksanovic D, Sanmugarajah J, Lunn D, Sawhney R, Eu K, Liang R (2021) Unmet needs in breast cancer survivors are common, and multidisciplinary care is underutilised: the Survivorship Needs Assessment Project. Breast Cancer 28(2):289–297

Koch L, Bertram H, Eberle A et al (2014) Fear of recurrence in long-term breast cancer survivors: still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship: a multi-regional population-based study. Psychooncology 23(5):547–554

Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M (2017) Estimation of the number of women living with metastatic breast cancer in the United States. Cancer Epidemiol Biomarkers Prev 26(6):809–815

Muradali D, Kennedy EB, Eisen A, Holloway CMB, Smith CR, Chiarelli AM (2017) Breast screening for survivors of breast cancer: a systematic review. Prev Med (Baltim) 103:70–75

Darby S, McGale P, Correa C et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 378(9804):1707–1716

Dong Y, Zhang WW, Wang J, Sun JY, He ZY, Wu SG (2019) The 21-gene recurrence score and effects of adjuvant radiotherapy after breast conserving surgery in early-stage breast cancer. Futur Oncol 15(14):1629–1639

Bradley R, Burrett J, Clarke M et al (2015) Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet 386(10001):1341–1352

Dent R, Trudeau M, Pritchard KI et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13(15):4429–4434

Siotos C, Naska A, Bello RJ et al (2019) Survival and disease recurrence rates among breast cancer patients following mastectomy with or without breast reconstruction. Plast Reconstr Surg 144(2):169e–177e

Voogd AC, Nielsen M, Peterse JL et al (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19(6):1688–1697

Chubak J, Yu O, Pocobelli G et al (2012) Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. J Natl Cancer Inst 104(12):931–940

Xu Y, Kong S, Cheung WY et al (2019) Development and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data. BMC Cancer 19:1

Ritzwoller DP, Hassett MJ, Uno H et al (2018) Development, validation, and dissemination of a breast cancer recurrence detection and timing informatics algorithm. J Natl Cancer Inst 110(3):273–281

Mariotto AB, Zou Z, Zhang F, Howlader N, Kurian AW, Etzioni R (2018) Can we use survival data from cancer registries to learn about disease recurrence? The case of breast cancer. Cancer Epidemiol Biomarkers Prev 27(11):1332–1341

Haque R, Shi J, Schottinger JE et al (2015) A hybrid approach to identify subsequent breast cancer using pathology and automated health information data. Med Care 53(4):380–385

Habbous S, Homenauth E, Barisic A et al (2022) Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study. C Open 10(2):E313–E330

Padmanabhan N, Subramanyan A, Radhakrishna S (2015) Synchronous bilateral breast cancers. J Clin Diagnostic Res 9(9):10–13

Botteri E, Bagnardi V, Rotmensz N et al (2009) Analysis of local regional recurrences in breast cancer after conservative surgery. Ann Oncol 21(4):723–728

Luo C, Zhong X, Deng L, Xie Y, Hu K, Zheng H (2019) Nomogram predicting locoregional recurrence to assist decision-making of postmastectomy radiation therapy in patients with T1–2N1 breast cancer. Int J Radiat Oncol Biol Phys 103(4):905–912

Tovar JR, Zandonade E, Amorim MHC (2014) Factors associated with the incidence of local recurrences of breast cancer in women who underwent conservative surgery. Int J Breast Cancer 2014:639534

Spronk I, Schellevis FG, Burgers JS, de Bock GH, Korevaar JC (2018) Incidence of isolated local breast cancer recurrence and contralateral breast cancer: a systematic review. Breast 39:70–79

Geurts YM, Witteveen A, Bretveld R et al (2017) Patterns and predictors of first and subsequent recurrence in women with early breast cancer. Breast Cancer Res Treat 165(3):709–720

Hassett MJ, Ritzwoller DP, Taback N et al (2014) Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using two large contemporary cohorts. Med Care 52(10):e65–e73

Warren JL, Mariotto A, Melbert D et al (2016) Sensitivity of Medicare claims to identify cancer recurrence in elderly colorectal and breast cancer patients. Med Care 54(8):e47–e54

Wapnir IL, Khan A (2019) Current strategies for the management of locoregional breast cancer recurrence. Oncol (United States) 33(1):19–25

Rasmussen LA, Jensen H, Virgilsen LF, Thorsen LBJ, Offersen BV, Vedsted P (2019) A validated algorithm for register-based identification of patients with recurrence of breast cancer—based on danish breast cancer group (DBCG) data. Cancer Epidemiol 59:129–134

Holloway CMB, Shabestari O, Eberg M et al (2022) Identifying breast cancer recurrence in administrative data: algorithm development and validation. Curr Oncol 29(8):5338–5367

Kroenke CH, Chubak J, Johnson L, Castillo A, Weltzien E, Caan BJ (2016) Enhancing breast cancer recurrence algorithms through selective use of medical record data. JNCI J Natl Cancer Inst 108(3):336

Habbous S, Forster K, Darling G et al (2020) Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study. Neuro-oncology Adv 3:1

Ontario Cancer Statistics 2020. 2020. https://www.cancercareontario.ca/en/statistical-reports/ontario-cancer-statistics-2020/ch-1-estimated-current-cancer-incidence. Accessed November 11, 2020

Pagani O, Senkus E, Wood W et al (2010) International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? JNCI J Natl Cancer Inst 102(7):456

Coleman M, Forman D, Bryant H et al (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377(9760):127–138

Miksad RA, Zietemann V, Gothe R et al (2008) Progression-free survival as a surrogate endpoint in advanced breast cancer. Int J Technol Assess Health Care 24(4):371–383

Kemp R, Prasad V (2017) Surrogate endpoints in oncology: When are they acceptable for regulatory and clinical decisions, and are they currently overused? BMC Med 15:1

Hernandez-Villafuerte K, Fischer A, Latimer N (2018) Challenges and methodologies in using progression free survival as a surrogate for overall survival in oncology. Int J Technol Assess Health Care 34(3):300–316

Seely JM, Alhassan T (2018) Screening for breast cancer in 2018—what should we be doing today? Curr Oncol 25(Suppl 1):S115–S124

Jones T, Duquette D, Underhill M et al (2018) Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry. Breast Cancer Res Treat 169(1):141–152

Zeng Z, Espino S, Roy A et al (2018) Using natural language processing and machine learning to identify breast cancer local recurrence. BMC Bioinformatics 19(Suppl 17):498